Moreno PLE, Hernández HIT, Moreno PR, García PG, García GD

Language: Spanish
References: 0
Page: 703-714
PDF size: 106.20 Kb.

ABSTRACT

Introduction: it was carried out a transversal observational study in the hospitalized patients with atrial fibrillation and ischemic stroke in the neurology service of Faustino Pérez Hospital in 2017.
Objective: To delineate the antithrombotic management in these patients prior to be admitted in the hospital in regard to embolism risk and bleeding risk, bleeding risk factors, antithrombotic therapy indicated.
Materials and methods: The universe of the study was 40 patients with AF and ischemic stroke. During the hospitalization of the patients were applied a survey to patients and/or their relatives for getting the information. The embolism risk and bleeding risk were defined according to CHA2DS2-VASc and HAS-BLED scales respectively.
Results: The most prevalence ages group was of the 75-84 year-old, in 95% of the patients the embolism risk was high, the most frequent bleeding risk factors for bleeding were age over 65 years and arterial hypertension with 95% y 85% respectively, in 70% bleeding risk was low and in patients with high bleeding risk the 20% carried a score of 3 points, 60% of the patients hadn’t antithrombotic therapy prior to be hospitalized with ischemic stroke, 35 % used antiplatelet Agents and only 5% used anticoagulants therapy.
Conclusion: The most hospitalized patients with ischemic stroke and AF had high embolism risk and low bleeding risk and should be treated with oral anticoagulant therapy. Oral anticoagulants are underused patients with atrial fibrillation despite of being associated with more survival.